Science Explorer Back to mapMap
Discussion
Researcher · University of Kentucky · United States

Lakshman Chelvarajan

Lakshman Chelvarajan publishes mostly in Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery, on topics such as Tissue Engineering and Regenerative Medicine, Cardiac Fibrosis and Remodeling and Sphingolipid Metabolism and Signaling.

OpenAlex
World rank
#4,985,324
of 7,710,434 ranked researchers
Rank in United States
#1,294,852
of 1,627,098
Works
31
Citations
477
Citations per work
15.4
h-index
15
i10-index 16Top 32% in Cardiology and Cardiovascular Medicine
Lakshman Chelvarajan

What does Lakshman Chelvarajan research?

Lakshman Chelvarajan's work is mostly in Medicine (40%), Biochemistry, Genetics and Molecular Biology (17%), Immunology and Microbiology (11%).

Health Sciences: 13 works · 40.5% of their workMedicine: 13 works · 40.5% of their workCardiology and Cardiovascular Medicine: 6 works · 20.2% of their workSurgery: 4 works · 11.9% of their workGenetics: 1 works · 4.8% of their workEpidemiology: 1 works · 3.6% of their workEverything else: 10 works · 32.1% of their workLife Sciences: 8 works · 27.4% of their workBiochemistry, Genetics and Molecular Biology: 5 works · 16.7% of their workMolecular Biology: 5 works · 16.7% of their workImmunology and Microbiology: 3 works · 10.7% of their workImmunology: 3 works · 10.7% of their workTHEIR WORKLakshmanChelvarajan31works
Life Sciences27%Health Sciences40%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1340.5%
  2. Everything else1032.1%
    1. Biochemistry, Genetics and Molecular Biology516.7%
    2. Immunology and Microbiology310.7%
  1. 1Cardiology and Cardiovascular Medicine20% of their works
  2. 2Molecular Biology17% of their works
  3. 3Surgery12% of their works
  4. 4Immunology11% of their works
  5. 5Genetics5% of their works
  6. 6Epidemiology4% of their works

Research topics

Which keywords describe Lakshman Chelvarajan's research?

The keywords of their largest research topics: Extracellular Matrix, Heart Failure, Macrophages, Decellularization, Organ Engineering, Insulin Resistance, Cardiac Remodeling and Epidemiology.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 21 words, with their numbers
  1. Extracellular Matrix142 topics
  2. Heart Failure92 topics
  3. Macrophages92 topics
  4. Decellularization81 topic
  5. Organ Engineering81 topic
  6. Insulin Resistance72 topics
  7. Cardiac Remodeling61 topic
  8. Epidemiology62 topics
  9. Inflammatory Response61 topic
  10. Mesenchymal Stem Cells41 topic
  11. Multipotent41 topic
  12. Sphingolipids41 topic
  13. Sphingosine-1-Phosphate41 topic
  14. Coronavirus31 topic
  15. Inflammation31 topic
  16. Myocarditis31 topic
  17. Obesity31 topic
  18. Porcine Reproductive and Respiratory Syndrome Virus31 topic
  19. Viral Infection31 topic
  20. Cardiomyocyte Renewal21 topic
  21. Heart Regeneration21 topic

Where does Lakshman Chelvarajan work?

Lakshman Chelvarajan's main affiliation in the publication record is University of Kentucky, United States.

How many publications and citations does Lakshman Chelvarajan have?

OpenAlex counts 31 works and 477 citations for Lakshman Chelvarajan, an h-index of 15, ranking #4,985,324 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Lakshman Chelvarajan. Posts are plain text and can be reported.